Axcelis Technologies filings document the formal disclosures of a semiconductor equipment company focused on ion implantation systems and lifecycle support. Its Form 8-K reports cover operating results, material events, financial-condition updates, executive officer changes and annual-meeting voting results.
Proxy materials describe board elections, stockholder voting mechanics, independent auditor ratification, executive compensation and share ownership by directors, officers and significant holders. The filing record also includes disclosures related to material agreements, governance matters and capital-structure subjects tied to the company’s common stock and public-company reporting obligations.
Chiu Tzu Yin reported acquisition or exercise transactions in this Form 4 filing.
Axcelis Technologies director Tzu Yin Chiu received a grant of 1,440 shares of Common Stock in the form of restricted stock units (RSUs). The RSUs were granted on May 15, 2026 at no cash cost and are scheduled to vest on May 15, 2027 assuming completion of the director’s current Board term. After this award, the director holds 11,843 shares directly, including 1,440 unvested RSUs that are subject to forfeiture.
Axcelis Technologies VP Corporate Controller Todd Sutton reported an open-market sale of 2,574 shares of common stock at a weighted-average price of $163.8946 per share, in multiple trades between $163.8067 and $164.1301. After this May 14, 2026 sale, he holds 7,817 shares directly, including 5,538 shares issuable upon vesting of restricted stock units granted under the 2012 Equity Incentive Plan that remain subject to forfeiture.
Axcelis Technologies executive Gerald M. Blumenstock, EVP of Research, Development & Engineering, reported an open-market sale of 1,015 shares of common stock on May 14, 2026 at an average price of $162.315 per share. Following this sale, he is shown with 17,293 shares that are issuable upon vesting of restricted stock units under the 2012 Equity Incentive Plan, all of which are subject to forfeiture. The footnote notes this amount includes restricted stock units earned based on achieving 112.5% of his 2025 performance-based restricted stock unit grant tied to 2025 performance goals.
Axcelis Technologies director Jorge Titinger reported an open-market sale of 2,000 shares of common stock on May 13, 2026 at a price of $164.14 per share. After this transaction, he directly held 4,477 shares, including 3,586 shares issuable upon vesting of restricted stock units that remain subject to forfeiture.
Axcelis Technologies EVP Greg Redinbo sold shares in an open-market transaction. On May 13, 2026, he sold 2,883 shares of common stock at $160.85 per share. After the sale, he held 29,823 shares, including 17,752 shares issuable upon vesting of restricted stock units that remain subject to forfeiture.
ACLS files a Form 144 reporting proposed sales of Common stock tied to restricted stock vesting under a registered plan. The excerpt lists vesting events dated 05/15/2023, 05/16/2023, 05/17/2023, and 05/15/2024 with per‑event share counts shown.
Morgan Stanley Smith Barney LLC submitted a Form 144 reporting the proposed sale of Common stock tied to restricted stock vesting under a registered plan dated 02/28/2026. The filing record shows an entry dated 05/14/2026 and lists numeric items including 164,749.73 and 30,734,000.
Axcelis Technologies EVP Global Operations Robert John Mahoney reported an open-market sale of 2,258 shares of Axcelis common stock on May 12, 2026 at a price of $161.00 per share. After this sale, he directly holds 12,759 shares. A footnote explains that 10,927 of these shares are issuable upon vesting of restricted stock units granted under the 2012 Equity Incentive Plan and remain subject to forfeiture, including units earned at 112.5% of a 2025 grant based on 2025 performance goals.
ACLS director Jorge Titinger filed a Form 144 reporting an intended sale of 2,000 shares of Common Stock. The filing lists the broker as Morgan Stanley Smith Barney LLC and is dated 05/13/2026. The filing also discloses a prior sale of 1,000 shares on 02/20/2026 for $80,000.
Morgan Stanley Smith Barney LLC filed a Form 144 proposing the sale of 2,883 shares of Common Stock of ACLS. The filing lists restricted stock vesting entries tied to the issuer on 06/15/2023, 05/16/2023, 06/15/2022, and 09/15/2023 with quantities 1,766, 453, 166, and 498 respectively.
The form shows an aggregate figure of $463,730.55 and a separate numeric field 30,719,000 as presented on the form. The filing lists NASDAQ as the market and Morgan Stanley Smith Barney LLC as the filer at the New York Plaza address.